Biphenotypic sinonasal sarcoma (BSNS) is an emerging subtype of sinonasal malignancy. It has not been previously well-studied but has characteristic gene fusion products and associated phenotypic features unique to it. Although rare, it has the potential to become large and infiltrate into bone over a prolonged period, with nonspecific preceding symptoms. It was first described in 2012, and more studies are needed before definitive decisions can be made regarding adjuvant treatments in addition to surgery. This activity reviews the evaluation, management, and overarching principles of BSNS and highlights the role of the healthcare team in evaluating and treating patients with this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/146341
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Otolaryngology, General Surgery, Head & Neck, Head & Neck/Oral, Internal Medicine, Medical Oncology, Surgical Pathology
Subscribe
Login
0 Comments
Oldest